PRIMARY HYPOGONADISM

This adverse event was reported 157 times

These drugs are most commonly taken by patients reporting PRIMARY HYPOGONADISM:

# Drug Count
0 CYCLOPHOSPHAMIDE 55
1 CYCLOPHOSPHAMIDE FOR INJECTION 55
2 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 55
3 BUSULFAN 38
4 ETOPOSIDE 34
5 METHOTREXATE SODIUM 15
6 METHOTREXATE 14
7 CYTARABINE 12
8 CISPLATIN 11
9 FINASTERIDE 11
See all common drugs associated with PRIMARY HYPOGONADISM

PRIMARY HYPOGONADISM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BETIBEGLOGENE AUTOTEMCEL 3 0.0536
1 CLOBETASOL PROPIONATE CREAM USP, 0.05% 1 0.0101
2 EQUINE THYMOCYTE IMMUNE GLOBULIN 3 0.0029
3 BUSULFAN 38 0.0024
4 IDARUBICIN HYDROCHLORIDE 2 0.0017
5 THIOGUANINE 3 0.0014
6 MITOTANE 2 0.0011
7 DACTINOMYCIN 2 0.0009
8 PSYLLIUM HUSK 1 0.0007
9 MITOXANTRONE HYDROCHLORIDE 4 0.0006
See all drugs enriched for association with PRIMARY HYPOGONADISM

PRIMARY HYPOGONADISM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 2 0.0009
1 Topoisomerase Inhibitor [EPC] 34 0.0004
2 Recombinant Human Growth Hormone [EPC] 8 0.0004
3 Alkylating Drug [EPC] 72 0.0003
4 Progesterone [EPC] 6 0.0003
5 Androgen [EPC] 6 0.0002
6 Lipid-based Polyene Antifungal [EPC] 2 0.0002
7 Bile Acid [EPC] 3 0.0001
8 5-alpha Reductase Inhibitor [EPC] 11 0.0001
9 Iron Chelator [EPC] 3 0.0001
See all drug classes enriched for association with PRIMARY HYPOGONADISM